Prosus’s red report card for underperformers Byju’s, PharmEasy

This is the third time Prosus has marked down its valuation of the beleaguered edtech firm within a year.

30 November, 20231 min
0
Prosus’s red report card for underperformers Byju’s, PharmEasy

You may also like

Business
Story image

India takes an unapologetic stand at COP30

As talks harden, India drags finance and fairness into the conversation at the annual climate summit.

Business
Story image

Why Kotak Mahindra Bank is in a hurry to swallow IDBI

As growth flatlines, acquisition of the government-controlled lender may be the only way out for the Uday Kotak-promoted bank to stay relevant.

Business
Story image

Mankind needs to get its mojo back

Once a stock market darling, the pharma company is bearing the brunt of a costly acquisition.